Exact Mass: 388.0907

Exact Mass Matches: 388.0907

Found 70 metabolites which its exact mass value is equals to given mass value 388.0907, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Betanidin

(1E)-1-{2-[(4E)-2,6-dicarboxy-1,2,3,4-tetrahydropyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1H-1λ⁵-indol-1-ylium-2-carboxylate

C18H16N2O8 (388.0907)


Minor congener of Betanidin. Isobetanidin is found in root vegetables. Isobetanidin is found in root vegetables. Minor congener of Betanidi

   

Dopaxanthin quinone

(4E)-4-[(2E)-2-{[1-carboxy-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]imino}ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid

C18H16N2O8 (388.0907)


Dopaxanthin quinone is produced by the reaction between dopaxanthin and oxygen, with water as a byproduct. A tyrosinase precursor enzyme catalyzes the reaction. [HMDB] Dopaxanthin quinone is produced by the reaction between dopaxanthin and oxygen, with water as a byproduct. A tyrosinase precursor enzyme catalyzes the reaction.

   

Triflupromazine hydrochloride

Triflupromazine hydrochloride

C18H20ClF3N2S (388.0988)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

   

2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid

2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid

C18H22Cl2O5 (388.0844)


   
   
   

Betanidin

Betanidin

C18H16N2O8 (388.0907)


D004396 - Coloring Agents > D050859 - Betacyanins D004396 - Coloring Agents > D050858 - Betalains

   

2-{[2,2,2-trifluoro-1-[(isopropoxycarbonyl)amino]-1-(trifluoromethyl)ethyl]amino}benzoic acid

2-{[2,2,2-trifluoro-1-[(isopropoxycarbonyl)amino]-1-(trifluoromethyl)ethyl]amino}benzoic acid

C14H14F6N2O4 (388.0858)


   
   
   

Ohioensin G

Ohioensin G

C23H16O6 (388.0947)


   

2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-

2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-

C18H16N2O8 (388.0907)


   

Violet-quinone

Violet-quinone

C23H16O6 (388.0947)


   
   

Ohioensin F

Ohioensin F

C23H16O6 (388.0947)


   

SCHEMBL11850526

SCHEMBL11850526

C16H20O11 (388.1006)


   

3,3-Methylenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

3,3-Methylenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

C23H16O6 (388.0947)


   

VER-50589

5-(5-Chloro-2,4-Dihydroxyphenyl)-N-Ethyl-4-(4-Methoxyphenyl)isoxazole-3-Carboxamide

C19H17ClN2O5 (388.0826)


   
   

Dopaxanthin quinone

Dopaxanthin quinone

C18H16N2O8 (388.0907)


   

Asp-Phe-OH

(S)-2-(3-(carboxymethoxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C18H16N2O8 (388.0907)


   

Phe-Asp-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)pentanedioic acid

C18H16N2O8 (388.0907)


   

Pamoic acid

Pamoic acid

C23H16O6 (388.0947)


Pamoic acid (Embonic acid) is a potent GPR35 agonist with an EC50 of 79 nM. Pamoic acid exhibits neuroprotective and anti-inflammatory properties[1][2].

   

tert-Butyl (3-((2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)carbamate

tert-Butyl (3-((2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)carbamate

C16H16ClF3N4O2 (388.0914)


   

2-[(4-chloro-2-nitrophenyl)azo]-N-(2,4-dimethylphenyl)-3-oxobutyramide

2-[(4-chloro-2-nitrophenyl)azo]-N-(2,4-dimethylphenyl)-3-oxobutyramide

C18H17ClN4O4 (388.0938)


   

2-(4-Boc-piperazinyl)-α-(3,4-dichloro-phenyl)acetic acid

2-(4-Boc-piperazinyl)-α-(3,4-dichloro-phenyl)acetic acid

C17H22Cl2N2O4 (388.0957)


   

dimethyl 4-[2,6-bis(methoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate

dimethyl 4-[2,6-bis(methoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate

C18H16N2O8 (388.0907)


   

5-chloro-2-[4-(1,3-dioxolan-2-yl)phenyl]-3-phenyl-1,6-naphthyridine

5-chloro-2-[4-(1,3-dioxolan-2-yl)phenyl]-3-phenyl-1,6-naphthyridine

C23H17ClN2O2 (388.0978)


   

triphenylcarbenium hexafluorophosphate

triphenylcarbenium hexafluorophosphate

C19H15F6P (388.0816)


   

2-(4-Boc-piperazinyl)-α-(2,4-dichloro-phenyl)acetic acid

2-(4-Boc-piperazinyl)-α-(2,4-dichloro-phenyl)acetic acid

C17H22Cl2N2O4 (388.0957)


   

2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSYL ISOTHIOCYANATE

2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSYL ISOTHIOCYANATE

C15H20N2O8S (388.094)


   

(5R)-5-(Chloromethyl)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl}-1,3-oxazolidin-2-one

(5R)-5-(Chloromethyl)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl}-1,3-oxazolidin-2-one

C17H14ClFN6O2 (388.0851)


   

diethyl 4,4-dinitro-[1,1-biphenyl]-2,2-dicarboxylate

diethyl 4,4-dinitro-[1,1-biphenyl]-2,2-dicarboxylate

C18H16N2O8 (388.0907)


   

2-[4-Methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one

2-[4-Methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one

C19H20N2O3S2 (388.0915)


   

DIETHYLENETRIAMINEPENTAACETATE

DIETHYLENETRIAMINEPENTAACETATE

C14H18N3O10-5 (388.0992)


   

2-(6-benzimidazolo[1,2-c]quinazolinylthio)-N-(2-furanylmethyl)acetamide

2-(6-benzimidazolo[1,2-c]quinazolinylthio)-N-(2-furanylmethyl)acetamide

C21H16N4O2S (388.0994)


   

5-Bromo-N[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide

5-Bromo-N[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide

C18H21BrN4O+2 (388.0899)


   

3-[4-(4-Luorophenyl)sulonylpiperazin-1-yl]chromen-4-one

3-[4-(4-Luorophenyl)sulonylpiperazin-1-yl]chromen-4-one

C19H17FN2O4S (388.0893)


   

2-Methylsulfonylmethyl-3,4,5-triacetoxybenzyl methyl ether

2-Methylsulfonylmethyl-3,4,5-triacetoxybenzyl methyl ether

C16H20O9S (388.0828)


   

2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid

2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid

C18H22Cl2O5 (388.0844)


   

2-Carboxy-1-[(2,6-dicarboxy-2,3-dihydro-4(1H)-pyridinylidene)ethylidene]-2,3-dihydro-5,6-dihydroxy-1H-indolium hydroxide inner salt

2-Carboxy-1-[(2,6-dicarboxy-2,3-dihydro-4(1H)-pyridinylidene)ethylidene]-2,3-dihydro-5,6-dihydroxy-1H-indolium hydroxide inner salt

C18H16N2O8 (388.0907)


   

(4E)-4-[2-[1-carboxy-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

(4E)-4-[2-[1-carboxy-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

C18H16N2O8 (388.0907)


   

N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide

N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide

C17H16N4O5S (388.0841)


   

N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydron;chloride

N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydron;chloride

C18H20ClF3N2S (388.0988)


   

N(6)-carbamoylmethyl-2-deoxyadenosine 5-monophosphate

N(6)-carbamoylmethyl-2-deoxyadenosine 5-monophosphate

C12H17N6O7P (388.0896)


A nucleoside monophosphate analogue that is dAMP in which one of the exocyclic amino hydrogens is replaced by a carbamoylmethyl group.

   

N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide

N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide

C17H16N4O5S (388.0841)


   

1-[(2-Carboxy-3-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid

1-[(2-Carboxy-3-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid

C23H16O6 (388.0947)


   

trans-Cinnamyl methyl 2-tosylmalonate

trans-Cinnamyl methyl 2-tosylmalonate

C20H20O6S (388.0981)


   

O-(N-acetylglucosamine-1-phosphoryl)-L-serine

O-(N-acetylglucosamine-1-phosphoryl)-L-serine

C11H21N2O11P (388.0883)


   
   

6-[3-(2,4-Dihydroxy-5-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[3-(2,4-Dihydroxy-5-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H20O11 (388.1006)


   

6-[3-(2,4-Dihydroxy-3-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[3-(2,4-Dihydroxy-3-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H20O11 (388.1006)


   

6-[4-(2-Carboxyethyl)-5-hydroxy-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[4-(2-Carboxyethyl)-5-hydroxy-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H20O11 (388.1006)


   

6-Hydroxyflavanone hydrogenephthalate

6-Hydroxyflavanone hydrogenephthalate

C23H16O6 (388.0947)


   

SB 204990

SB 204990

C18H22Cl2O5 (388.0844)


SB 204990 is a potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme.

   

(2r)-2-carboxy-1-{2-[(2r)-2-carboxy-6-carboxylato-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

(2r)-2-carboxy-1-{2-[(2r)-2-carboxy-6-carboxylato-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

C18H16N2O8 (388.0907)


   

1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

C16H20O11 (388.1006)


   

5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol

5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol

C19H20N2O3S2 (388.0915)


   

βetanidin

NA

C18H16N2O8 (388.0907)


{"Ingredient_id": "HBIN018102","Ingredient_name": "\u03b2etanidin","Alias": "NA","Ingredient_formula": "C18H16N2O8","Ingredient_Smile": "C1C(NC(=CC1=CC=[N+]2C(CC3=CC(=C(C=C32)O)O)C(=O)[O-])C(=O)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2320","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

betanidin

betanidin radical

C18H16N2O8 (388.0907)


{"Ingredient_id": "HBIN018205","Ingredient_name": "betanidin","Alias": "betanidin radical","Ingredient_formula": "C18H16N2O8","Ingredient_Smile": "C1C(N=C(C=C1C=CN2C(CC3=CC(=C(C=C32)O)O)C(=O)O)C(=O)O)C(=O)O","Ingredient_weight": "388.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT18318","TCMID_id": "23207","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137218006","DrugBank_id": "NA"}

   

(1r,15r,23s)-4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one

(1r,15r,23s)-4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one

C23H16O6 (388.0947)


   

6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one

6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one

C23H16O6 (388.0947)


   

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

C16H20O11 (388.1006)


   

4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one

4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one

C23H16O6 (388.0947)


   

(1r,14r,15s,23s)-6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one

(1r,14r,15s,23s)-6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one

C23H16O6 (388.0947)


   

8,18-dihydroxy-20-methoxy-6,16-dimethyl-12-oxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17,20-nonaene-3,10-dione

8,18-dihydroxy-20-methoxy-6,16-dimethyl-12-oxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17,20-nonaene-3,10-dione

C23H16O6 (388.0947)


   

(1s,4as,7as)-1-{[(2s,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

(1s,4as,7as)-1-{[(2s,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid

C16H20O11 (388.1006)


   

(2s)-4-[(1e)-2-[(2r)-2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

(2s)-4-[(1e)-2-[(2r)-2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

C18H16N2O8 (388.0907)


   

(2r,5'r,7s,7as)-5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol

(2r,5'r,7s,7as)-5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol

C19H20N2O3S2 (388.0915)


   

5-hydroxy-3-[(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)methyl]-2-methylnaphthalene-1,4-dione

5-hydroxy-3-[(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)methyl]-2-methylnaphthalene-1,4-dione

C23H16O6 (388.0947)